146 related articles for article (PubMed ID: 12143307)
1. [Establishment of a hemophilia B transgenic mouse model on the basis of coagulation factor IX gene knock-out mouse].
Che WL; He Y; Yao ZZ; Li J; Fu JL
Yi Chuan Xue Bao; 2002 Jul; 29(7):594-8. PubMed ID: 12143307
[TBL] [Abstract][Full Text] [Related]
2. Factor IX: Insights from knock-out and genetically engineered mice.
Monahan PE
Thromb Haemost; 2008 Oct; 100(4):563-75. PubMed ID: 18841277
[TBL] [Abstract][Full Text] [Related]
3. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
[TBL] [Abstract][Full Text] [Related]
5. [Vector construction for embryonic stem cell gene targeting of site specific point mutation mouse coagulation factor IX gene].
Li J; Dai X; Yang H; Fu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):356-9. PubMed ID: 10581342
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
[TBL] [Abstract][Full Text] [Related]
7. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
Tanimoto M; Matsushita T; Takamatsu J; Saito H
Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
[TBL] [Abstract][Full Text] [Related]
8. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells].
Hou J; Wang J; Min B
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060
[TBL] [Abstract][Full Text] [Related]
9. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
Brooks MB; Gu W; Ray K
J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.
Matthews RJ; Anson DS; Peake IR; Bloom AL
J Clin Invest; 1987 Mar; 79(3):746-53. PubMed ID: 3029178
[TBL] [Abstract][Full Text] [Related]
12. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C
Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634
[TBL] [Abstract][Full Text] [Related]
13. [Four novel point mutations of factor IX gene detected by denaturing gradient gel electrophoresis].
Wang Y; Li Z; Wan H
Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):125-8. PubMed ID: 11243142
[TBL] [Abstract][Full Text] [Related]
14. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of hepatocyte transplantation on hemophilia B.
Tatsumi K; Ohashi K; Shima M; Nakajima Y; Okano T; Yoshioka A
Transplantation; 2008 Jul; 86(1):167-70. PubMed ID: 18622295
[TBL] [Abstract][Full Text] [Related]
16. DNA analysis of seven patients with hemophilia B who have anti-factor IX antibodies: relationship to clinical manifestations and evidence that the abnormal gene was inherited.
Tanimoto M; Kojima T; Kamiya T; Takamatsu J; Ogata K; Obata Y; Inagaki M; Iizuka A; Nagao T; Kurachi K
J Lab Clin Med; 1988 Sep; 112(3):307-13. PubMed ID: 3411192
[TBL] [Abstract][Full Text] [Related]
17. [Non-viral gene transfer results in therapeutic factor IX levels in haemophilia B mice].
Schüttrumpf J; Milanov P; Roth S; Seifried E; Tonn T
Hamostaseologie; 2008 Oct; 28 Suppl 1():S92-5. PubMed ID: 18958345
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human clotting factor IX cDNA expression in transgenic mice.
Hu Y; Qiu X; Xue J; Liu Z
Sci China B; 1995 Jul; 38(7):825-33. PubMed ID: 7626202
[TBL] [Abstract][Full Text] [Related]
19. [Methylation of the factor IX gene--a basic reason for the mutation causing hemophilia B].
Mazin AL
Mol Biol (Mosk); 1995; 29(1):71-90. PubMed ID: 7723765
[TBL] [Abstract][Full Text] [Related]
20. Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing.
Karimipoor M; Zeinali S; Nafissi N; Tuddenham EG; Lak M; Safaee R
Thromb Res; 2007; 120(1):135-9. PubMed ID: 17014892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
